We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Longeveron has completed enrollment in its Phase 1 Alzheimer's disease trial. This randomized, double-blind, placebo-controlled study is designed to evaluate the safety and ...